According to a new report published by K D Market Insights, titled, “Transcatheter Aortic Valve Replacement Market Insights, Trends, Opportunity & Forecast, 2023–2032,” the global transcatheter aortic valve replacement market size is anticipated to witness moderate growth during the forecast period i.e., 2023-2032. The escalating prevalence of cardiac diseases and the aging population which are the major factors augmenting the growth of the global transcatheter aortic valve replacement market. The global transcatheter aortic valve replacement market is anticipated to grow at a moderate CAGR of 7% from 2023 to 2032. The market's revenue surged to $5.5 billion in 2022, and it is expected to further accelerate, reaching a notable $10.8 billion by 2032.

Technological advancements play a pivotal role in improving patient outcomes and expanding the eligible patient population, is further expected to create ample growth opportunities for the global transcatheter aortic valve replacement market during the forecast period i.e., 2023-2032. Moreover, the increasing demand for minimally invasive techniques fuels the adoption of TAVR procedures, has propelled market expansion. The rising prevalence of aortic valve diseases, such as aortic stenosis, in the aging population, is expected to contribute towards the market growth during the period.

The North America region accounted for the largest share in the global transcatheter aortic valve replacement market in 2022. The region is further projected to continue dominating in the market during the forecast period. This can be attributed to the robust healthcare facilities, the presence of major market players, and a high incidence of cardiac diseases.

According to procedures, the transfemoral implantation segment accounted for the largest market share in the transcatheter aortic valve replacement market in 2022 and is further expected to continue with the trend during the forecast period i.e., 2023 – 2032.

The global transcatheter aortic valve replacement market is segmented into procedures, end-users and region. Based on procedures, the market is bifurcated into transfemoral implantation, transapial implantation, and transaortic implantation. Based on end-users, it is classified into hospitals, ambulatory surgical centers, and others.

The global transcatheter aortic valve replacement market is analyzed across North America (U.S. & Canada), Europe (Germany, United Kingdom, France, Italy, Spain, Russia, and Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Indonesia, Thailand, Australia, New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and the Rest of Latin America) and Middle East & Africa (GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, and Rest of Middle East & Africa).

Key Insights of Transcatheter Aortic Valve Replacement Market

  • On the basis of procedures, the transfemoral implantation segment accounted for the largest market share in the transcatheter aortic valve replacement market in 2022 and is further expected to continue with the trend during the forecast period i.e., 2023 – 2032.
  • On the basis of region, North America accounted for the largest share in the global transcatheter aortic valve replacement market in 2022. The region is further projected to continue dominating in the market during the forecast period.
  • On the basis of region, Asia-Pacific is estimated to account for the second largest share in the market during the forecast period.

Some of the major transcatheter aortic valve replacement companies profiled in the report include CryoLife, Inc., Abbott, Micro Interventional Devices, Inc., Boston Scientific Corporation, LivaNova PLC, Meril Life Sciences Pvt. Ltd., Edwards Lifesciences Corporation, Medtronic, Auto Tissue Berlin GmbH, Lepu Medical Technology Co. Ltd., Neovasc Inc., TTK HealthCare, and JenaValve Technology, Inc.

Related Healthcare Reports :-

https://www.kdmarketinsights.com/reports/animal-healthcare-market/3294

https://www.kdmarketinsights.com/reports/e-clinical-solution-software-market/3268

https://www.kdmarketinsights.com/reports/nootropics-market/3212

https://www.kdmarketinsights.com/reports/dyslipidemia-therapeutics-market/3070